Orozco SBE, Meléndez RE, Marchán CJC, Pereira RL, Máttar S

Language: Spanish
References: 8
Page: 20-23
PDF size: 168.56 Kb.

ABSTRACT

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. Cutaneous tuberculosis is a rare clinical presentation among cases of extrapulmonary tuberculosis. Clinical subtypes of cutaneous tuberculosis and its various manifestations are diverse. The subtypes present diagnostic difficulties. The current report contributes valuable information as it provides tools for health professionals to suspect and diagnose cutaneous tuberculosis. We present a 67-year-old male with a history of pulmonary tuberculosis. He consulted for xeroderma; however, in the clinical exploration, we found a fistulized lesion with inverted borders located on a previous surgical scar. The diagnosis was achieved by skin biopsy with Ziehl-Neelsen stain. The first phase of treatment consisted of two months with isoniazid, rifampicin, pyrazinamide, and ethambutol, and the second phase of four months with rifampicin and isoniazid. The suspicion of cutaneous tuberculosis was confirmed as scrofuloderma.

REFERENCES

1. Mederos Cuervo L, Acosta Suárez M, Cálas Echevarría V, CárdenasGarcía A, Galarza Hernández M, León Canga R et al., Caso inusual detuberculosis cutánea por Mycobacterium tuberculosis en paciente consíndrome de inmunodeficiencia adquirida, Rev Soc Ven Microbiol 2017;37(1):30-3.

2. Monera J, Montoya L, Mosquera J, Benavides A y Sarmiento J, Casosde tuberculosis pulmonar y extrapulmonar notificados al Programade Tuberculosis en el departamento del Chocó, Colombia, periodo2012-2015, Enf Infec Microbiol 2019; 39(3).

3. Gupta S y Roy R, Scrofuloderma: a rare case report of sequelae ofintestinal tuberculosis, Int J Dermatol Venereol 2021; 4(3):185-7. doi:10.1097/JD9.0000000000000165.

4. Bernardes R, Siviero E y Ribeiro I, Scrofuloderma: a diagnostic challenge,An Bras Dermatol 2019; 94(1):102-4. doi: 10.1590/abd1806-4841.20188560.

5. Oberhelman S, Watchmaker J y Phillips T, Scrofuloderma, jama Dermatol2019; 155(5):610. doi:10.1001/jamadermatol.2018.5651.

6. Rifin S, Shalihin M, Jidin M y Tahar M, Scrofuloderma: a diagnosticdilemma in primary care, Med J Malaysia 2021; 76(3).

7. Molgó M, Cárdenas C, Ramonda P y Salinas M, Escrofuloderma: tuberculosiscutánea y pulmonar asociada a coinfección covid-19. Reportede caso, Rev Med Chile 2021; 149:630-4. doi.org/10.4067/s0034-98872021000400630.

8. Ministerio de Salud y Protección Social, Resolución 227 de 2020. Lineamientostécnicos y operativos del programa nacional de prevención ycontrol de la tuberculosis, 20 de febrero de 2020.